Categories

Popular tags

All Formulations
Moxifloxacin 5mg/mL
Add this to my Favorites list

Moxifloxacin Injectable 0.5%

(Moxifloxacin 5mg/mL)
  • Unit Size: 1 ML
  • Package Size: 20 per Box
  • Package Price: $330.00
Shipped in boxes of 20 vials

Free ground shipping. Single-use vials.

Click here for the full package insert.
SKU: 300000011364262
Manufacturer part number: DL003
Box(es) of 20
Specifications
  • Unit Type: Vial
  • Classification: Injectable
  • Sub-Classification: Solution
  • Storage: Room Temperature
  • NDC Number: 71384-511-01
  • Preservative Free
Related Formulations
Dex-Moxi Injectable

Dex-Moxi® Injectable

(Dexamethasone 1mg and moxifloxacin 5mg/mL)
  • Unit Size: 1 ML/Unit
  • Package Size: 20
  • Package Price: $550.00
Box(es) of 20
Epi-Lido Injectable

Epi-Lido Injectable

(Lidocaine 0.75% and epinephrine in BSS 0.025%)
  • Unit Size: 1 ML/Unit
  • Package Size: 20
  • Package Price: $330.00
Box(es) of 20
Picture of MKO Melt®

MKO Melt®

(Midazolam 3mg, ketamine 25mg and ondansetron 2mg)
  • Unit Size: 1 EA/Unit
  • Package Size: 21
  • Package Price: $346.50
Box(es) of 21
Customers who bought this item also bought
Tri-Moxi Injectable

Tri-Moxi™ Injectable

(Triamcinolone acetonide 15mg and moxifloxacin hydrochloride 1mg/mL)
  • Unit Size: 0.6 ML/Unit
  • Package Size: 20
  • Package Price: $484.00
Box(es) of 20
Phenyl-Lido Injectable

Phenyl-Lido Injectable

(Phenylephrine 1.5% and lidocaine 1%)
  • Unit Size: 1 ML/Unit
  • Package Size: 20
  • Package Price: $330.00
Box(es) of 20
Epi-Lido Injectable

Epi-Lido Injectable

(Lidocaine 0.75% and epinephrine in BSS 0.025%)
  • Unit Size: 1 ML/Unit
  • Package Size: 20
  • Package Price: $330.00
Box(es) of 20
Picture of MKO Melt®

MKO Melt®

(Midazolam 3mg, ketamine 25mg and ondansetron 2mg)
  • Unit Size: 1 EA/Unit
  • Package Size: 21
  • Package Price: $346.50
Box(es) of 21
*For professional use only. Imprimis Pharmaceuticals specializes in customizing medications to meet unique patient and practitioner needs. No compounded medication is reviewed by the FDA for safety or efficacy. Imprimis Pharmaceuticals does not compound copies of commercially available products. References available upon request.